IL10 and type 1 diabetes mellitus: In this study, we conducted combined intervention of IL-10 and IGF-1 in NOD mice with diabetes at onset stage and evaluated its protective effects on the residual islet β- cells, hoping to provide a theoretical basis for early clinical treatment of T1D.